Crohn's disease

PredictImmune's test relies on a 16-marker panel run using quantitative PCR to stratify Crohn's disease and ulcerative colitis patients according to the severity of their illnesses.

The panel is designed to measure genetic markers in whole-blood samples in order to predict which patients are likely to experience a severe, relapsing form of the disease.

Biogen will now be able to supply Lisa Tracker monitoring kits in the competitive tenders in which it participates in France and other parts of Europe.